Chemical formula: C₂₃H₂₅F₅N₂O₄S Molecular mass: 520.146 g/mol PubChem compound: 154617563
The mechanism of action of oveporexton in the treatment of narcolepsy type 1 (NT1) is through agonism of the orexin receptor 2 (OX2R). NT1 is associated with the loss of orexin neuropeptide signaling.
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Document | Type | Information Source | |
|---|---|---|---|
| ORZEYFUL Tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
Oveporexton is an active ingredient of these brands:
United States (US)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.